Discover
RCEL
AVITA Medical, Inc.
4.67
2 x 3.48
2 x 5.31
bid
ask
+
0.54
13.08%
2 @ 04:00 PM
4.60 -0.07 (1.50%)
| Ytd | 35.36% | |
| 1y | -11.39% |
4.15
day range
4.85
3.22
52 week range
7.12
| Open | 4.16 | Prev Close | 4.13 | Low | 4.15 | High | 4.85 | Mkt Cap | 143.73M |
| Vol | 611.91K | Avg Vol | 282.05K | EPS | -1.56 | P/E | N/A | Forward P/E | -14.33 |
| Beta | 1.54 | Short Ratio | 10.24 | Inst. Own | 23.45% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 4.25 | 200-d Avg | 4.26 | 1yr Est | 16.81 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-07 | 2024-09 | -0.42 | -0.62 | -0.2 | -47.62% |
| 2024-08-08 | 2024-06 | -0.59 | -0.6 | -0.01 | -1.69% |
| 2024-05-13 | 2024-03 | -0.26 | -0.73 | -0.47 | -180.77% |
| 2024-02-22 | 2023-12 | -0.34 | -0.28 | 0.06 | 17.65% |
| 2023-11-09 | 2023-09 | -0.53 | -0.34 | 0.19 | 35.85% |
| 2023-08-10 | 2023-06 | -0.34 | -0.41 | -0.07 | -20.59% |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-11-08 | Piper Sandler | Upgrade | Neutral | Neutral |
| 2024-08-09 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
| 2024-05-14 | Piper Sandler | Downgrade | Overweight | Neutral |
| 2024-05-14 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
| 2024-04-11 | BTIG | Downgrade | Buy | Neutral |
| 2024-02-23 | Piper Sandler | Upgrade | Overweight | Overweight |
Profile
AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Blackrock Inc. | 1.86M | 21.86M | 7.10% |
| 2024-09-29 | Vanguard Group Inc | 1.42M | 16.66M | 5.41% |
| 2024-09-29 | Geode Capital Management, LLC | 594.44K | 6.98M | 2.27% |
| 2024-09-29 | State Street Corporation | 520.00K | 6.11M | 1.98% |
| 2024-09-29 | Essex Investment Management Co LLC | 231.09K | 2.72M | 0.88% |
| 2024-09-29 | Northern Trust Corporation | 216.47K | 2.54M | 0.83% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 800.72K | 9.41M | 3.05% |
| 2024-10-30 | iShares Russell 2000 ETF | 656.68K | 7.72M | 2.50% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 389.20K | 4.57M | 1.48% |
| 2024-08-30 | Fidelity Small Cap Index Fund | 262.42K | 3.08M | 1.00% |
| 2024-10-30 | iShares Russell 2000 Growth ETF | 231.65K | 2.72M | 0.88% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 145.15K | 1.71M | 0.55% |
Split
| Split | Date |
|---|---|
| 1 : 5 | 2020-06-30 |